Bath & Body Works, Inc. $BBWI Stock Position Raised by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 5.4% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 378,264 shares of the company’s stock after purchasing an additional 19,329 shares during the period. Segall Bryant & Hamill LLC owned about 0.18% of Bath & Body Works worth $11,333,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Bath & Body Works by 7.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after purchasing an additional 781,681 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock worth $212,120,000 after acquiring an additional 733,000 shares in the last quarter. Alliancebernstein L.P. boosted its position in Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock worth $164,397,000 after acquiring an additional 243,611 shares during the period. AQR Capital Management LLC grew its stake in Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after acquiring an additional 2,907,506 shares in the last quarter. Finally, GMT Capital Corp increased its holdings in shares of Bath & Body Works by 7.3% in the 1st quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock valued at $113,327,000 after purchasing an additional 255,600 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

BBWI has been the subject of several research reports. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Baird R W lowered shares of Bath & Body Works from a “strong-buy” rating to a “hold” rating in a research note on Friday. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $39.00 to $17.00 in a research note on Thursday. Jefferies Financial Group reduced their price objective on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research report on Monday, October 13th. Finally, JPMorgan Chase & Co. dropped their target price on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating on the stock in a research report on Thursday. Seven investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $26.90.

Bath & Body Works Trading Down 6.2%

Shares of NYSE:BBWI opened at $14.84 on Friday. The stock has a market capitalization of $3.06 billion, a PE ratio of 4.40, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $41.87. The firm has a fifty day moving average price of $24.58 and a 200 day moving average price of $28.13.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works’s quarterly revenue was down 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a yield of 5.4%. Bath & Body Works’s dividend payout ratio is presently 24.62%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.